Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
drug approval system
You should not take Semaglutide or Tirzepatide if you: Have a family history of medullary thyroid cancer (MEN Type 2) Have Type 1 diabetes or a history of diabetic ketoacidosis (DKA) Have experienced pancreatitis Have severe kidney or liver disease Are allergic to GLP-1 or GIP medications How Do These Medications Work
Individuals with cardiovascular disease or significant cardiovascular risk factors should generally favor Mounjaro pending cardiovascular outcome trial data for Retatrutide
Effects of Retatrutide on body composition in people with type 2 diabetes (substudy)
What does LIPO-C contain
At Embla, we help employers deliver better weight loss outcomes with less medication, fewer side effects, and more sustainable results.Talk to our team tolearn how we help self-funded employers launch structured, high-impact GLP-1 benefits
